In other radiopharmaceuticals news, Sydney, Australia-based AdvanCell announced in February 2025 that it had successfully completed an oversubscribed, $112 million round of Series C financing (2). The ...

Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of ...

The targeted radiopharmaceutical field is undergoing significant expansion, with progressing clinical candidates and growing novel pipelines. Precision radiopharmaceuticals represent a golden ...

At close: April 21 at 10:38:56 AM CST ...